title: Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells.
abstract: In vitro sensitivity of HT29 human colon cancer cells to doxorubicin (DXR), vincristine (VCR), etoposide (VP16), cisplatin (CDDP), melphalan (L-PAM) and 5-fluorouracil (5FU) was markedly reduced when cell-culture density increased. For some drugs, confluence-dependent resistance (CDR) was partly due to decreased intracellular drug accumulation; the ratio of mean intracellular drug content of non confluent to confluent cells (NC/C) was 2.5 for DXR, 4.1 for VCR and 7.4 for VP16. Altered drug penetration with confluence could be related to decrease of plasma membrane fluidity as measured by the fluorescence polarization method. Reduction of drug intracellular accumulation was nil or weak for L-PAM (NC/C = 1.0), CDDP (NC/C = 1.2) and 5 FU (NC/C = 1.8). Even if drug concentration was adjusted in culture medium to produce similar intracellular drug content in confluent and non confluent cells, higher intrinsic resistance of confluent cells was still evidenced for DXR and VP16 but not for VCR, the only agent without direct interaction with DNA. DXR- and VP16-induced DNA breakage was also less important in confluent than in non-confluent cells. CDR appeared closely related to an increased proportion of non-cycling cells at confluence, as demonstrated by flow cytometry, expression of nuclear antigen recognized by Ki67 MAb and expression of topoisomerase II. CDR is probably a major factor in the poor sensitivity of colorectal adenocarcinomas to chemotherapy.
authors.affiliation: Research Group on Digestive Tumors, INSERM U252, Faculty of Medicine, Dijon, France.
authors.forename: M T
authors.initials: MT
authors.lastname: Dimanche-Boitrel
authors.forename: H
authors.initials: H
authors.lastname: Pelletier
authors.forename: P
authors.initials: P
authors.lastname: Genne
authors.forename: J M
authors.initials: JM
authors.lastname: Petit
authors.forename: C
authors.initials: C
authors.lastname: Le Grimellec
authors.forename: P
authors.initials: P
authors.lastname: Canal
authors.forename: C
authors.initials: C
authors.lastname: Ardiet
authors.forename: G
authors.initials: G
authors.lastname: Bastian
authors.forename: B
authors.initials: B
authors.lastname: Chauffert
mesh_terms: D000970:Antineoplastic Agents / Q000378:metabolism*; D002455:Cell Division; D003110:Colonic Neoplasms / Q000378:metabolism / Q000473:pathology*; D004249:DNA Damage; D004351:Drug Resistance; D006801:Humans; D008560:Membrane Fluidity; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents